HomeAI · summaries
Storia in 4 fonti
Wegovy-maker Novo Nordisk warns of 'painful' price cuts as shares slump
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk tumbles 11% after forecasting sales declines this year
The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.
- ·
Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets better
Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise prereleased its 2026 forecast late Tuesday, sending shares tumbling.
